Newly appointed head of the Drug Enforcement Administration (DEA), Chuck Rosenberg, says that marijuana is “probably” not as dangerous as heroin.
Rosenberg’s comments, issued Tuesday, are seemingly in conflict with marijuana’s Schedule I classification under federal law, which places it in the same category as heroin and is a lesser category than cocaine. The law defines cannabis and its dozens of distinct cannabinoids as possessing “a high potential for abuse … no currently accepted medical use, … [and] a lack of accepted safety for the use of the drug … under medical supervision.”
Predictably, Rosenberg did emphasize that he believed cannabis posed potential harms, stating:“If you want me to say that marijuana’s not dangerous, I’m not going to say that because I think it is. Do I think it’s as dangerous as heroin? Probably not. I’m not an expert.”
However, Rosenberg acknowledged that he has asked DEA offices “to focus their efforts and the resources of the DEA on the most important cases in their jurisdictions, and by and large what they are telling [him] is that the most important cases in their jurisdictions are opioids and heroin.”
Rosenberg’s predecessor, Michelle Leonhart vigorously defended marijuana’s Schedule I classification. She oversaw dozens of raids on medical marijuana providers, criticized the President on his remarks of marijuana’s safety in relation to alcohol, and rejected an administrative petition calling for marijuana rescheduling hearings. NORML is pleased that although the new DEA administrator, by his own admission is not “an expert” on cannabis, he apparently possesses a better grasp on marijuana and it’s evident differences compared to other schedule 1 substances.
Rosenberg’s comments, coupled with those of NIDA Director Nora Volkow publically espousing the safety of CBD indicate that it may no longer be a question of if the federal government will move to reclassify cannabis but when.
The director of the US National Institute on Drug Abuse (NIDA), Nora Volkow, believes that cannabidiol (CBD) – a nonpsychotropic cannabinoid – is “a safe drug with no addictive effects.” Volkow made the comments in an op-ed published by The Huffington Post.
Volkow further acknowledged, “[P]reliminary data suggest that it may have therapeutic value for a number of medical conditions.”
Preclinical studies have documented CBD to possess a variety of therapeutic activities, including anti-cancer properties, anti-diabetic properties, and bone-stimulating activity. Clinical and observational trials have documented the substance to possess anxiolytic, anti-psychotic, and anti-seizure activity in humans. Safety trials have further concluded the substance to be “safe and well tolerated” when administered to healthy subjects.
To date, 15 states have enacted laws specifically permitting the possession of high-CBD formulated extracts for therapeutic purposes, primarily for the treatment of pediatric epilepsy.
In a recent Time Magazine op-ed, Democrat Sen. Diane Feinstein (CA) and Republican Sen. Charles Grassley (IA) encouraged the Obama administration to “definitively determine if CBD has scientific and medical benefits,” and to “look at expanding compassionate access programs where possible, to benefit as many children as possible.”
Under federal law, CBD — like cannabis — is defined as a Schedule I controlled substance with “a high potential for abuse … no currently accepted medical use, … [and] a lack of accepted safety for the use of the drug … under medical supervision.”
Senate Bill 460 permits state-licensed medical marijuana dispensaries to also engage in cannabis sales to non-medical persons beginning on October 1, 2015. Adults will be allowed to purchase up to one-quarter ounce of cannabis per visit per day.
Initiated legislation approved by voters in November and enacted on July 1 allows those over the age of 21 to legally possess up to one ounce of cannabis and/or to engage in the non-commercial cultivation of up to four marijuana plants (yielding up to eight ounces of marijuana). Separate provisions in the law permitting the licensed production and retail sale of cannabis to adults were not anticipated to go into effect until next summer. Senate Bill 60 permits adults to legally obtain cannabis from dispensaries during this interim period.
Alaska, Colorado, Oregon and Washington permit adults to legally possess and purchase limited quantities of marijuana for their own personal use. The District of Columbia also allows adults to possess and grow marijuana legally, but does not provide for as regulated commercial cannabis market. All of these measures were enacted by the passage of voter initiatives.
Hello NORML Supporters!
That’s why we’re announcing the NORML Nation Membership Drive, taking place from August 5th to August 12th!
We’re working with multiple partners in the cannabis industry to build NORML’s ranks. The goal of this membership drive is to add 1,000 new members to NORML! We’re offering three ways to participate:
$25 Donor Package
- Green “I Leaf NORML” Shirt (New design!)
- Merchandise from Hemp Wick, Weed Maps, Mass Roots, and more!
$50 Supporter Package
- Limited Edition NORML Nation Shirt (Only available in this drive!)
- Complimentary issue of Freedom Leaf Magazine
- Everything in the Donor Package
$100 Advocate Package
- 30% off 1 month of 420 Goody Box
- Weed Maps T-shirt
- Special promotion from Spliffin (Details will be announced soon!)
- Everything in the Donor and Supporter Packages
In addition to all of the cool merchandise you will get with becoming a member of the NORML Nation, we are also going to help all new members get connected with their local NORML chapters! The best part about being a NORML member is getting involved in your local area to push for marijuana law reform. We’re also holding a contest for our local chapters, by offering monetary grants to the chapters that refer the most people to National NORML!
The NORML Nation Membership Drive starts next Wednesday, August 5th and goes for a week, until August 12th. The 2016 election season is right around the corner, so this is the perfect time to get involved with cannabis legalization and support NORML!
Stay tuned for more updates about the NORML Nation Membership Drive!
While America’s public support for domestic prohibition of marijuana appears increasingly waning, quantifying the types of marijuana law reforms internationally could constitute a full time job for the eager.
This day’s news alone from overseas about cannabis law reforms strongly suggests that the contagion to end pot prohibition is hardly an America-only phenomena:
Israel – The country’s deputy health minister announced today that medical cannabis will be made available for retail access via commercial pharmacies.
Italy – Cannabis law reform group in Italy claims 250 out of 945 members of Italian Parliament support ending pot prohibition, which is a little more than twenty-five percent of the country’s elected policymakers. Drafted by the Intergrupo Parlamentare Cannabis Legale, the legislation would allow anyone over the age of 18 to cultivate as many as five plants at home. Italians could also team up to form a “cannabis social club,” with each having a maximum of 50 people growing as many as 250 plants.
Surveys in Italy indicate that nearly eighty percent of citizens support the country adopting marijuana laws similar to American states Colorado and Washington.
United Kingdom – A twenty-five year old economics student in the United Kingdom has forced the hand of parliament to debate the issue of marijuana legalization by submitting a petition with over one hundred thousand signatures.
Australia’s Queensland – Joining New South Wales, the Australian state of Queensland took steps to formalize a system by which qualified medical patients can access cannabis products via a series of research trials.
Portugal – California’s Press Enterprise’s editorial board reminds all that the week marks the fourteenth anniversary of the first nation, Portugal, to entirely decriminalize drug use and possession, which is serving as a ‘harm reduction’ model for numerous countries.